Project Inform
   

PI Action alerts & updates ... 2006

PI Comments on Proposed Ryan White CARE Act
Reauthorization Legislation

May 12, 2006

TO: Senators Enzis and Kennedy and Representatives Barton and Dingell
FROM: Ryan Clary, Associate Director of Health Care Advocacy, Project Inform

On behalf of Project Inform, a national HIV/AIDS treatment and health care advocacy organization, I want to thank you and your staffs for your hard work in producing bipartisan, bicameral legislation to reauthorize the Ryan White CARE Act. We greatly appreciate the thoughtful process you undertook to craft a bill that maintains the current structure of the program, while responding to changes in the HIV epidemic without destabilizing systems of care. We also appreciate this opportunity to provide feedback on your proposed legislation before it is considered by your colleagues in the House and Senate.

As a member of the Communities Advocating Emergency AIDS Relief (CAEAR) Coalition, we endorse all of the recommendations offered in CAEAR’s formal response to your reauthorization proposal.

In particular, we urge that the Title I hold harmless provision be maintained for four years, instead of the three proposed in your legislation, at the percentages of 90, 85, 80, and 75. This will allow jurisdictions to maintain stability in the provision of care while transitioning to the new funding criteria.

We also strongly urge the creation of a Title II supplemental mechanism that directs funding through a formula to states without Title I EMAs and the two states (Ohio and Louisiana) with more than 50 percent of their cases outside their EMAs. We support an authorization level of $70 million for this supplemental, and directing the $70 million increase to Title II base -- as proposed by the President in his Fiscal Year 2007 budget -- to this fund. A sign-on letter supported by a broad range of HIV/AIDS advocacy organizations endorsing the $70 million Title II supplemental is being sent to you separately.

Separate from the recommendations that are included in CAEAR’s response, Project Inform agrees with the National Alliance of State and Territorial AIDS Directors (NASTAD) that ADAP Supplemental Grants should be strengthened in order to help states provide a minimal level of service to those in need. To that end, the ADAP Supplemental should be expanded from 3% to 5% of the ADAP appropriation.

We agree with your recommendation not to tie eligibility for the ADAP Supplemental to what was available on January 1, 2000. We support NASTAD’s recommendation on new eligibility requirements for the Supplemental:

1. Gross income eligibility criteria of at or less than 300 percent of Federal Poverty Level (FPL);

2. Inadequate formulary (lack of coverage of any FDA-approved antiretroviral drugs or the PHS-recommended drugs for treatment and prophylaxis of opportunistic infections for individuals with incomes at or less than 300 percent of FPL; or

3. Waiting lists of ADAP applicants with incomes at or less than 300 percent of FPL.

Additionally, we support the elimination of the match requirement for the ADAP Supplemental. While we strongly encourage state contributions, we know that this state match can be a major barrier for some of the states most in need.

We believe that the inclusion of a formula-based, $70 million Title II supplemental, the extension of the ADAP Supplemental from 3% to 5%, and allowing Title I hold-harmless to remain for four years will help reach your goals of responding to changes in the epidemic without dismantling systems of care, while maintaining the structure of the CARE Act.

Thank you for considering our comments as you finalize legislation, and for your hard work and leadership on behalf of people living with HIV/AIDS. If you have any questions, please contact me at 415-558-8669 x224 or rclary@projectinform.org.

ARCHIVES OF
ALERTS / UPDATES

2008

2007     2006

2005     2004

2003     2002

2001     2000

1999     1998

1997     1996

 
     
 

© 2008 Project Inform  1375 Mission Street,  San Francisco, CA 94103  415-558-8669
National HIV/AIDS Treatment Hotline 1-800-822-7422 (415-558-9051 local/int'l) 10a-4p Mon-Fri PST